Summary Immunological markers improve specificity and accuracy of cell detection, therefore it is important to evaluate their usefulness in improving standard histological procedures.
Prognosis and treatment of breast cancer is heavily influenced by the detection of metastases in lymph nodes. Foci formed by clumps of cells are easily spotted in standard histological sections, but a more difficult task is the detection of metastatic foci of one or few cells spread within a tissue.
In as many as 24% of lymph nodes reported free of metastases by standard histological examination, various authors found metastases when multiple or serial sections were cut (Pickren, 1961; Fisher et al., 1978b) . Immunological markers also improve the specificity and accuracy of cell detection, therefore it is important to evaluate their usefulness in improving standard histological procedures. Wells et al. (1984) utilizing 3 monoclonal antibodies found micro-metastatic foci in about 20% of lymph nodes from 45 cases of ductal or lobular breast cancer reported negative on conventional histology. On the contrary Sloane et al. (1980) reached the conclusion that detection of metastases in lymph nodes was not improved by immunocytochemistry. However they used a polyclonal antiserum against fat globule membranes of human milk.
In this study 50 cases of infiltrating lobular carcinoma of the breast reported to have axillary lymph nodes free of metastases were re-examined to determine whether occult metastases were revealed by a higher number of sections and by immunocytochemical procedures and, in cases where metastatic cells could be detected immunocytochemically, whether a substantial difference in results using monoclonal antibodies and polyclonal antisera was demonstrable.
Cases of infiltrating lobular carcinoma rather than the more common ductal carcinoma were examined, because metastatic spread from the former is difficult to diagnose since neoplastic cells are often 'benign-looking' (Ashton et al., 1975) and tend to fill the sinuses, mimicking sinus histiocytosis (Rosai, 1981) , or to invade the lympho-reticular tissue in a lymphoma-like pattern difficult to detect on standard histological sections (McDivitt et al., 1968) .
Materials and methods
The specimens consisted of axillary lymph nodes which had been removed at surgery for infiltrating lobular breast carcinoma (ILC) (Hsu et al., 1981) was used, with a minor modification to avoid non specific staining of mast cells (Bussolati & Gugliotta, 1983) . Endogenous peroxidase was abolished by the hydrogen peroxide-periodic acidborohydride sequence (Heyderman & Neville, 1977 (Altmannsberger et al., 1981) , gives a weak but specific staining of breast cancer metastatic cells also in formalin-fixed tissues.
One of the sections was used as a control, treated with normal mouse serum (diluted 1:50) and then processed with horse anti-mouse biotinylated antibody and the ABC procedure.
In special cases, to identify immunocytochemically positive cells, photographs of the corresponding area of serial H&E stained slides were taken. The slide was then unmounted and processed first with standard treatment to abolish the endogenous peroxidase (which removes both haematoxylin and eosin stains) and then for immunocytochemistry. The morphology of the cells could then be easily recognized and pictures of the same cells, before and after immunocytochemistry, compared.
To identify macrophages, rabbit antisera against chymotrypsin and alpha-I anti-trypsin were employed (both diluted 1:100; from Dako, Denmark). These enzymes are regarded as macrophage markers (Motoi et al., 1980; Isaacson et al., 1981) .
Results
Metastatic ILC cells gave a strong reaction with a similar distribution with both the anti-EMA serum and HMFG-2 antibody, in one case however a group of metastatic cells was positive only with the former. The staining was mainly localized over the cell surface and in occasional intra-cytoplasmic vacuoles with the typical 'targetoid' pattern (Eusebi et al., 1977) . A faint diffuse cytoplasmic staining was also a rather common finding.
The anti-keratin antibody gave a negative reaction in lymphoid cells and a definite, although rather weak, staining of ILC metastatic cells. It was thus better not to rely on the use of this monoclonal for recognizing metastatic cells at lowmagnification scanning: this was instead feasible on sections stained with the anti-EMA serum. The two monoclonals on serial sections were a useful control of the results obtained with the anti-EMA serum.
In one case anti-EMA serum markedly stained small cytoplasmic dots in a large number of cells located mostly in the peripheral sinuses. This finding was present in an appreciable number of cells in another 5 cases. These cells were interpreted as macrophages because of the positive staining on serial sections with chymotrypsin and alpha-I antitrypsin and the oval, clear nucleus with ample, star-like cytoplasm (Figure la-c) . These cells were totally unreactive with anti-keratin serum.
Occult metastases were detected by the antisera in 12 of the 50 cases examined with a total of 26 positive lymph nodes out of the 767 lymph nodes examined.
Metastatic cells occurred mostly as isolated, noncohesive cells either in the sinuses or in the diffuse lymphoid tissue. In the sinuses they appeared between histiocytes and occasionally filled the sinuses in a rather compact fashion (Figure 2) . In some cases, no or very few epithelial metastatic cells were observed in the sinuses, while positive cells were scattered in a diffuse pattern between lymphoid cells in the cortex and medulla (Figure  3a, b; 4a, b) .
Examination of the H&E sections serial to the immunocytochemically stained ones identified cancer cells in 7 nodes (5 cases) out of the 26 positive lymph nodes. An independent observer reached the same conclusion. In one of the 5 histologically positive cases, cancer cells were found to be present already in the original slides.
In the other 7 cases, the isolated distribution of the metastatic cells described above seems the main reason for failure to detect them by morphology. This was clearly shown when H&E and peroxidase stained photomicrographs of the same cells were compared (Figure 4a, b) . Furthermore, cells of infiltrating lobular carcinoma often show a vesicular inconspicuous nucleus and ample cytoplasm which makes them resemble reactive histiocytic cells. The follow up of all 50 cases for a minimum of 2 and a maximum of 7 years (mean 3.5 years) showed that 2 of the 12 (17%) immunocytochemically positive cases, and 7 (2 of whom died) of the 38 (18%) negative cases, had recurrences.
Discussion
This study focuses on the use of immunocytochemistry to detect metastatic breast cancer cells from infiltrating lobular carcinoma (ILC). In a preliminary study in 10 cases of infiltrating ductal carcinoma originally classified as node negative we could not find any advantage in the use of immunocytochemistry (unpublished observation).
Small metastatic foci were detected in 2 cases, but these could be already recognized in serial H&E sections. Sloane & coworkers (1980) The results of this study revealed occult metastatic foci in 24% of the cases of ILC with lymph nodes originally classified as negative. Of these only 10% were also revealed by serial sectioning. These figures lead us to conclude that in contrast with the results of our above mentioned preliminary study and with those of Sloane et al.
(1980), immunocytochemistry has definite advantages over routine histological examination. An explanation of these contrasting conclusions possibly lies in the fact that, contrary to the more common ductal carcinoma, ILC cells metastasize to lymph nodes and elsewhere (Ashton et al., 1975) immunostaining Altmannsberger et al., 1981) . Anti-EMA serum is known to stain occasional lymphoid cells (Delsol et al., 1984) . For unknown reasons such staining is mainly observed in lymphomas, but in our and in other workers' experience (Sloane et al., 1983) this does not usually happen in reactive lymph nodes. Plasma cells did occasionally show a faint staining of the cell membrane with anti-EMA serum; their nature however could be easily interpreted.
The newly discovered positivity in the lymph nodes of 12 cases was evidently determined by very small foci of metastatic cells that can be defined as micrometastatic because if they had been large foci they would probably have been detected in the original morphological examination. Fisher et al. (1978a) in agreement with Huvos et al. (1971) and with Attiyeh et al. (1977) observed that in breast cancer patients in whom micrometastases measured less than 1.3 mm, the survival and treatment rates were similar to those of node-negative patients. Rosen & coworkers (1981) observed, however, that patients with micrometastatic spread in axillary lymph nodes behaved, after a long follow up (twelve years), as high risk patients.
The follow up period and the number of cases studied in our series are both too small for us to reach conclusions on whether immunocytochemically positive lymph node cases previously diagnosed at morphology as negative (therefore probably micrometastatic) carry a worse prognosis than cases that remain negative all along. However in this case series (with its already mentioned limitations) we did not find that the 24% of lymph node positive cases had an increased frequency of recurrences or a shortened survival time.
Having now determined the technical utility of immunocytochemistry we intend studying a large series with long term follow up to determine whether it also improves prognostic accuracy.
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